vs
Enact Holdings, Inc.（ACT）与COLLEGIUM PHARMACEUTICAL, INC（COLL）财务数据对比。点击上方公司名可切换其他公司
Enact Holdings, Inc.的季度营收约是COLLEGIUM PHARMACEUTICAL, INC的1.5倍（$312.7M vs $205.4M），COLLEGIUM PHARMACEUTICAL, INC同比增速更快（12.9% vs 3.6%），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs 3.6%）
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商，为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案，帮助首付较低的购房者获得可负担的住房贷款，助力更多美国普通消费者实现安居需求。
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
ACT vs COLL — 直观对比
营收规模更大
ACT
是对方的1.5倍
$205.4M
营收增速更快
COLL
高出9.3%
3.6%
两年增速更快
COLL
近两年复合增速
3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $312.7M | $205.4M |
| 净利润 | — | $17.0M |
| 毛利率 | — | 62.5% |
| 营业利润率 | 71.3% | 29.6% |
| 净利率 | — | 8.3% |
| 营收同比 | 3.6% | 12.9% |
| 净利润同比 | — | 35.3% |
| 每股收益（稀释后） | $1.23 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTCOLL
| Q4 25 | $312.7M | $205.4M | ||
| Q3 25 | $311.5M | $209.4M | ||
| Q2 25 | $304.9M | $188.0M | ||
| Q1 25 | $306.8M | $177.8M | ||
| Q4 24 | $301.8M | $181.9M | ||
| Q3 24 | $309.6M | $159.3M | ||
| Q2 24 | $298.8M | $145.3M | ||
| Q1 24 | $291.6M | $144.9M |
净利润ACTCOLL
| Q4 25 | — | $17.0M | ||
| Q3 25 | — | $31.5M | ||
| Q2 25 | — | $12.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $12.5M | ||
| Q3 24 | — | $9.3M | ||
| Q2 24 | — | $19.6M | ||
| Q1 24 | — | $27.7M |
毛利率ACTCOLL
| Q4 25 | — | 62.5% | ||
| Q3 25 | — | 61.7% | ||
| Q2 25 | — | 57.7% | ||
| Q1 25 | — | 54.8% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | — | 60.8% | ||
| Q2 24 | — | 62.5% | ||
| Q1 24 | — | 63.1% |
营业利润率ACTCOLL
| Q4 25 | 71.3% | 29.6% | ||
| Q3 25 | 67.4% | 29.7% | ||
| Q2 25 | 70.4% | 18.7% | ||
| Q1 25 | 68.9% | 12.2% | ||
| Q4 24 | 68.9% | 20.9% | ||
| Q3 24 | 74.1% | 21.9% | ||
| Q2 24 | 78.6% | 32.7% | ||
| Q1 24 | 70.6% | 34.1% |
净利率ACTCOLL
| Q4 25 | — | 8.3% | ||
| Q3 25 | — | 15.0% | ||
| Q2 25 | — | 6.4% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 6.9% | ||
| Q3 24 | — | 5.9% | ||
| Q2 24 | — | 13.5% | ||
| Q1 24 | — | 19.1% |
每股收益（稀释后）ACTCOLL
| Q4 25 | $1.23 | $0.48 | ||
| Q3 25 | $1.10 | $0.84 | ||
| Q2 25 | $1.11 | $0.34 | ||
| Q1 25 | $1.08 | $0.07 | ||
| Q4 24 | $1.05 | $0.36 | ||
| Q3 24 | $1.15 | $0.27 | ||
| Q2 24 | $1.16 | $0.52 | ||
| Q1 24 | $1.01 | $0.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $582.5M | $386.7M |
| 总债务越低越好 | $744.5M | — |
| 股东权益账面价值 | $5.4B | $301.7M |
| 总资产 | $6.9B | $1.7B |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势，按日历期对齐
现金及短期投资ACTCOLL
| Q4 25 | $582.5M | $386.7M | ||
| Q3 25 | $545.6M | $285.9M | ||
| Q2 25 | $616.0M | $222.2M | ||
| Q1 25 | $639.0M | $197.8M | ||
| Q4 24 | $602.8M | $162.8M | ||
| Q3 24 | $674.9M | $120.0M | ||
| Q2 24 | $711.3M | $271.6M | ||
| Q1 24 | $624.3M | $318.0M |
总债务ACTCOLL
| Q4 25 | $744.5M | — | ||
| Q3 25 | $744.1M | — | ||
| Q2 25 | $743.8M | — | ||
| Q1 25 | $743.4M | — | ||
| Q4 24 | $743.0M | — | ||
| Q3 24 | $742.7M | — | ||
| Q2 24 | $742.4M | — | ||
| Q1 24 | $746.1M | — |
股东权益ACTCOLL
| Q4 25 | $5.4B | $301.7M | ||
| Q3 25 | $5.3B | $274.8M | ||
| Q2 25 | $5.2B | $232.2M | ||
| Q1 25 | $5.1B | $234.4M | ||
| Q4 24 | $5.0B | $228.8M | ||
| Q3 24 | $5.0B | $234.3M | ||
| Q2 24 | $4.8B | $216.6M | ||
| Q1 24 | $4.7B | $222.2M |
总资产ACTCOLL
| Q4 25 | $6.9B | $1.7B | ||
| Q3 25 | $6.9B | $1.6B | ||
| Q2 25 | $6.8B | $1.6B | ||
| Q1 25 | $6.7B | $1.6B | ||
| Q4 24 | $6.5B | $1.7B | ||
| Q3 24 | $6.6B | $1.6B | ||
| Q2 24 | $6.3B | $1.1B | ||
| Q1 24 | $6.3B | $1.1B |
负债/权益比ACTCOLL
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.14× | — | ||
| Q1 25 | 0.15× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $724.5M | $123.0M |
| 自由现金流经营现金流 - 资本支出 | — | $122.4M |
| 自由现金流率自由现金流/营收 | — | 59.6% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | 7.25× |
| 过去12个月自由现金流最近4个季度 | — | $327.6M |
8季度趋势，按日历期对齐
经营现金流ACTCOLL
| Q4 25 | $724.5M | $123.0M | ||
| Q3 25 | $192.0M | $78.4M | ||
| Q2 25 | $119.5M | $72.4M | ||
| Q1 25 | $226.7M | $55.4M | ||
| Q4 24 | $686.3M | $84.6M | ||
| Q3 24 | $188.1M | $-9.0M | ||
| Q2 24 | $144.7M | $67.4M | ||
| Q1 24 | $187.3M | $61.9M |
自由现金流ACTCOLL
| Q4 25 | — | $122.4M | ||
| Q3 25 | — | $78.3M | ||
| Q2 25 | — | $72.4M | ||
| Q1 25 | — | $54.6M | ||
| Q4 24 | — | $84.1M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $67.1M | ||
| Q1 24 | — | $61.4M |
自由现金流率ACTCOLL
| Q4 25 | — | 59.6% | ||
| Q3 25 | — | 37.4% | ||
| Q2 25 | — | 38.5% | ||
| Q1 25 | — | 30.7% | ||
| Q4 24 | — | 46.2% | ||
| Q3 24 | — | -5.8% | ||
| Q2 24 | — | 46.2% | ||
| Q1 24 | — | 42.3% |
资本支出强度ACTCOLL
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.4% |
现金转化率ACTCOLL
| Q4 25 | — | 7.25× | ||
| Q3 25 | — | 2.49× | ||
| Q2 25 | — | 6.05× | ||
| Q1 25 | — | 22.92× | ||
| Q4 24 | — | 6.75× | ||
| Q3 24 | — | -0.96× | ||
| Q2 24 | — | 3.44× | ||
| Q1 24 | — | 2.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
